NCT07064733 Effect of Music and Warm Foot Bath Therapy on Pregnancy-Related Anxiety, Blood Pressure and Quality of Life
| NCT ID | NCT07064733 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kırklareli University |
| Condition | Primigravida Women |
| Study Type | INTERVENTIONAL |
| Enrollment | 144 participants |
| Start Date | 2025-06-06 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 144 participants in total. It began in 2025-06-06 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study Title: The Effects of Music Therapy and Warm Foot Bath on Pregnancy-Related Stress, Blood Pressure, and Quality of Life in Low-Risk Primigravida Women Brief Summary: This randomized controlled trial investigates the impact of music therapy and warm foot bath therapy on pregnancy-related anxiety, blood pressure levels, and quality of life in low-risk primigravida pregnant women. Participants will be randomly assigned into four groups: music therapy, warm foot bath therapy, combined therapy, and control group. The interventions will be carried out for 2 weeks with pre- and post-assessments of anxiety and quality of life.
Eligibility Criteria
Inclusion Criteria: * 18-39 years of age, * Literate; able to make an informed decision to participate, communicate verbally, and sign a consent form * Pregnant with a single, live fetus * Have a smartphone * Low-risk primigravida pregnant with a gestational age of 26 weeks or more Exclusion Criteria: * \- Having hearing impairment, * Refusing to participate, * Being illiterate, * Having communication problems, * Being hospitalized with severe preeclampsia, * The newborn not surviving. * Antepartum hemorrhage * Preeclampsia, * Gestational hypertension, * Cervical insufficiency, * Having pregnancy-related complications such as congenital fetal anomalies and intrauterine growth restriction diagnosed before 28 weeks of gestation or having multiple pregnancies; * Having psychiatric disorders (known anxiety or depression, other illnesses), * Having medical problems such as endocrine disorders (gestational diabetes mellitus, thyroid dysfunction, etc.); * Having assisted reproductive techniques (ART) such as in vitro fertilization, embryo transfer, or * Pregnant women at risk of preterm birth will not be included in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07064733 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 39 Years, studying Primigravida Women. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07064733 currently recruiting?
Yes, NCT07064733 is actively recruiting participants. Contact the research team at nerminkayar24@gmail.com for enrollment information.
Where is the NCT07064733 trial being conducted?
This trial is being conducted at Edirne, Turkey (Türkiye).
Who is sponsoring the NCT07064733 clinical trial?
NCT07064733 is sponsored by Kırklareli University. The trial plans to enroll 144 participants.